The rise of copyright’s blockbuster initially fueled a boom for pharma, however recent developments present a uncertain outlook for those considering a stake. Off-patent competitors are eroding profits, and https://sahilyeap322033.blogs100.com/41577810/sildenafil-and-big-pharma-a-volatile-play